Robert May 2024 Scaled Aspect Ratio 1200 384

Our Leadership

  • Robert Ang

    Robert Ang, MBBS, MBA

    President and Chief Executive Officer

    Robert Ang, MBBS, MBA, is President and CEO at Vor Bio since 2019. Prior to Vor Bio, Robert gained operational experience focused on strategy and business development through roles at Neon Therapeutics (now BioNTech), Bavarian Nordic, and Cadence Pharmaceuticals (now Mallinckrodt). Robert also has biotech ...

  • Vorbiopharma Tania Philip Sq

    Tania Philipp

    Chief People Officer

    Tania Philipp, Chief People Officer, brings more than 20 years of experience helping early-stage life sciences companies grow and progress. As a member of the senior leadership team, she is responsible for building a skilled and experienced team that will help Vor Bio achieve its ...

President and Chief Executive Officer

Robert Ang, MBBS, MBA

Robert Ang, MBBS, MBA, is President and CEO at Vor Bio since 2019. Prior to Vor Bio, Robert gained operational experience focused on strategy and business development through roles at Neon Therapeutics (now BioNTech), Bavarian Nordic, and Cadence Pharmaceuticals (now Mallinckrodt). Robert also has biotech venture capital experience at Frazier Healthcare Ventures, where he invested in companies such as Incline Therapeutics (now Novartis) and Alnara Pharmaceuticals (now Eli Lilly), and strategy consulting experience at the Boston Consulting Group. He also has general surgery training and his clinical practice centered around soft tissue surgery with an emphasis on solid organ transplants. He received his medical degree at the University of Western Australia and has an MBA with Honors from Columbia Business School. Robert also serves as an independent director at the early-stage cancer immunotherapy company Enara Bio, a member of the Board of Directors and Vice-Chair of the Alliance for Regenerative Medicine, and a member of the Healthcare and Pharmaceutical Management Advisory Board of Columbia Business School.

Learn more about Robert’s views on the industry, the workplace, and other business topics in his CEO Perspectives blog.

 

Robert Ang

Chief People Officer

Tania Philipp

Tania Philipp, Chief People Officer, brings more than 20 years of experience helping early-stage life sciences companies grow and progress. As a member of the senior leadership team, she is responsible for building a skilled and experienced team that will help Vor Bio achieve its objectives. Tania has a passion for creating a collaborative company culture and for fostering team dynamics that support individual and organizational growth. Prior to joining Vor Bio, she was Vice President and Head of Human Resources at Tango Therapeutics, where she was responsible for developing and implementing the strategic human resources vision that supported the company’s objectives and defined its culture. Before Tango, Tania held various senior human resources positions for a number of companies, including Bavarian Nordic, Mendel Biotechnology, Sunesis Pharmaceuticals, Pearl Therapeutics (acquired by AstraZeneca), and Protein Design Labs. Tania holds a master’s degree in behavioral psychology from The University of the Pacific.

Tania Philip

From the Vor Bio team

“The leadership team at Vor leads by example. They bring their authentic selves in the office, they attend company events, and they interact with everyone at every level of the company. They truly care about the people here and making the best experience for everyone.”

Janet Gee
Associate Director
Financial Planning and Analysis

“We have access to all of our executives, which is a huge advantage. They truly take an interest in helping employees grow, learn and develop. This genuine mentorship is something that makes Vor stand out.”

Lee Schwartz
Senior Director, HRBP
Human Resources

Join The Vor Bio team

Collaborate
to change
the world

Join a passionate team advancing the science and shaping the future of cancer treatments.

Board of Directors

Our Board members offer expert global biopharma experience and perspective.